Salix

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 4 drugs with upcoming expirations

Activity

Key Events

Feb 9, 2024FDAPulmicort — EOHILIA

Dec 15, 2021FDAPulmicort — TARPEYO

Jun 13, 2019FDAPulmicort — ORTIKOS

Jan 19, 2017FDATrulance — TRULANCE

Jul 19, 2016FDARelistor — RELISTOR

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

18 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Xifaxan4 patentsFeb 27, 2026 Pulmicort6 patentsNov 9, 2026 RelistorAug 3, 2027 XifaxanSep 2, 2027 TrulanceJan 30, 2028 Pulmicort2 patentsNov 12, 2028 Xifaxan15 patentsFeb 26, 2029 Pulmicort3 patentsMay 7, 2029

10 more

Relistor5 patentsSep 30, 2029 RelistorDec 31, 2030 Relistor5 patentsMar 10, 2031 Pulmicort5 patentsSep 7, 2031 Trulance3 patentsSep 15, 2031 Trulance2 patentsMar 1, 2032 Trulance4 patentsJun 5, 2034 Pulmicort2 patentsSep 9, 2036 Pulmicort2 patentsJan 10, 2039 Pulmicort4 patentsJan 23, 2043

Regulatory

Regulatory Timeline

19822 events

FDAJan 1

Diuril — DIURIL

Application NDA011145 (NDA)

FDAJan 1

Diuril — DIURIL

Application NDA011870 (NDA)

19941 event

FDAFeb 14

Pulmicort — RHINOCORT

Application NDA020233 (NDA)

19971 event

FDAJun 24

Pulmicort — PULMICORT

Application NDA020441 (NDA)

20001 event

FDAAug 8

Pulmicort — PULMICORT RESPULES

Application NDA020929 (NDA)

20011 event

FDAOct 2

Pulmicort — ENTOCORT EC

Application NDA021324 (NDA)

20041 event

FDAMay 25

Xifaxan — XIFAXAN

Application NDA021361 (NDA)

20061 event

FDAJul 12

Pulmicort — PULMICORT FLEXHALER

Application NDA021949 (NDA)

20101 event

FDASep 27

Relistor — RELISTOR

Application NDA021964 (NDA)

20131 event

FDAJan 14

Pulmicort — UCERIS

Application NDA203634 (NDA)

20141 event

FDAOct 7

Pulmicort — UCERIS

Application NDA205613 (NDA)

20151 event

FDAMar 23

Pulmicort — RHINOCORT ALLERGY

Application NDA020746 (NDA)

20161 event

FDAJul 19

Relistor — RELISTOR

Application NDA208271 (NDA)

20171 event

FDAJan 19

Trulance — TRULANCE

Application NDA208745 (NDA)

20191 event

FDAJun 13

Pulmicort — ORTIKOS

Application NDA211929 (NDA)

20211 event

FDADec 15

Pulmicort — TARPEYO

Application NDA215935 (NDA)

20241 event

FDAFeb 9

Pulmicort — EOHILIA

Application NDA213976 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)